Filling and Closing System Reduces Decontamination Cycle
The FlexPro 50, from Groninger, is a modular filling and closing system designed to process vials, cartridges, and syringes, as well as vials in bulk and trays.
The FlexPro 50, from Groninger, is a modular filling and closing system designed to process vials, cartridges, and syringes, as well as vials in bulk and trays. FlexPro 50 lines can be executed with manual or fully automated process steps. Nested vials, cartridges, and syringes can be processed on one line configuration by changing format parts. Additional flexibility is given by exchanging the machine trolleys to process vials in trays or in bulk in the same line configuration.
The FlexPro 50 can produce an output of up to 4700 objects per hour. The isolator works independently of a facility’s HVAC system. Gloves on the front and back of the main and add-on isolators allow machine access from both sides. The new Direct-Injection-System reduces the decontamination cycle by approximately 50%. The line can be changed to process different products in around two hours.
Groninger
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Pfizer Obtains Exclusive Rights to 3SBio’s Bispecific Antibody Targeting PD-1 and VEGF
July 25th 2025The licensing agreement between the two companies gives Pfizer the rights to develop, manufacture, and commercialize 3SBio’s bispecific antibody, SSGJ-707, which is in clinical trials for the treatment of a variety of cancers.
Mechanistic Hypothesis of Toxicity: Driving Decision Making in Preclinical Translation
July 16th 2025Mechanistic toxicity hypothesis is essential in guiding decision-making and predicting toxicities during the preclinical stages of drug development. The authors highlight the growing importance of integrating advanced technologies like mass spectrometry imaging into toxicology to enhance preclinical translation, foster innovation in therapeutic development, and ultimately improve drug safety and efficacy.
